BIT
NERV icon

BlackRock Institutional Trust’s Minerva Neurosciences NERV Stock Holding History

BlackRock Institutional Trust’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$3.56M Buy
37,831
+5,288
+16% +$540K ﹤0.01% 2847
2016
Q3 		$3.67M Buy
32,543
+15,786
+94% +$1.53M ﹤0.01% 2814
2016
Q2 		$1.37M Buy
+16,757
New +$1.07M ﹤0.01% 3192

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock Institutional Trust's NERV Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Minerva Neurosciences (NERV) stake by 16% in Q4 2016, buying an estimated $540K and bringing the position to 37,831 shares worth $3.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2847.

BlackRock Institutional Trust first reported a position in NERV in Q2 2016 and has held it in 3 quarters since. The position peaked at $3.67M in Q3 2016. 78 funds tracked by Wall St. Rank hold NERV as of Q4 2016.

  • BlackRock Institutional Trust held 37,831 shares of Minerva Neurosciences worth $3.56M as of Q4 2016.
  • BlackRock Institutional Trust bought 5,288 Minerva Neurosciences shares in Q4 2016, an estimated $540K.
  • Minerva Neurosciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2847 holding.
  • BlackRock Institutional Trust first reported a position in Minerva Neurosciences in Q2 2016 and has held it in 3 quarters since.
  • BlackRock Institutional Trust's Minerva Neurosciences position peaked at $3.67M in Q3 2016.
  • 78 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.